The National Medical Products Administration announced the results of flight inspections for three companies.

The National Medical Products Administration recently conducted on-site inspections on Harbin Mixue'er Cosmetics Co., Ltd., Heshi Biological Technology Co., Ltd., and Coslife International Trade (Shenzhen) Co., Ltd., and found that these companies violated relevant regulations, with serious defects in their production quality management systems. The National Medical Products Administration has ordered the relevant provincial drug supervision and administration departments to investigate and handle the violations in accordance with the law. Currently, the companies have been filed for investigation and their production and operation have been temporarily suspended.